Temple Research Finds That Tweaking CBD May Help It Curb Pain And Opioid Use In Mice

The next generation of cannabis-inspired medicine might be grown in test tubes instead of greenhouses.

Researchers at Temple University have partnered with Doylestown-based pharmaceutical company Neuropathix to develop a synthetic molecule based on cannabidiol (CBD) that can provide more potent pain relief than CBD itself. They are currently studying it in a type of chronic pain caused by nerve damage due to chemotherapy. The CBD-based drug could offer an appealing alternative to addictive opioids and milder painkillers to treat chronic pain.

“We see CBD and possibly CBD analogs as giving us a different type of tool that’s not only safer than opioids, but maybe more effective because it’s working in a different way,” said Sara Jane Ward, assistant professor of pharmacology at the Lewis Katz School of Medicine at Temple University.

– Read the entire article at The Philadephia Inquirer.

Read More Here…

Share on facebook
Share on twitter
Share on reddit
Share on pinterest
Share on email

Bud Digest

This entry was posted in Vaporizer E-Cigarette Stocks News. Bookmark the permalink. Follow any comments here with the RSS feed for this post. Post a comment or leave a trackback.

Leave a Reply

Your email address will not be published. Required fields are marked *

Your email address will never be published.